scholarly journals Mastectomia subcutánea con reconstruccion inmediata del complejo areolo-mamilar en transexuales masculinos

2020 ◽  
Vol 72 (5) ◽  
Author(s):  
Patricio Stevens Moya
Keyword(s):  

Introducción: Se presenta experiencia realizada en Servicio de Salud Talcahuano, de masculinización mamaria en el proceso de reasignación sexual, de transexuales masculinos. En Chile se estima que habrían  754 mujeres transexuales. Metodología: Estudio de 47 individuos, intervenidos en Hospital Las Higueras de Talcahuano, entre 2006 y 2019, sometidos a masculinización mamaria mediante mastectomía subcutánea y  reconstrucción del complejo areolomamilar. Resultados: Se intervinieron pacientes de todo el país; 59% corresponde a octava región; 42,5 % operados entre los años  2017 y  2018. Un 36% rango de edad  de 18 a 22 años. Un 68%  IMC entre 24 y 30. Según el tamaño de las mamas,  57 % copa B,  31%  C, 12%  D y 12 % de gigantomastia. Un 29 %, peso promedio de la mastectomía  fue de 600 gramos; un 29% de 300 gramos y en 9 %  mas de 800 gramos por lado. En 68% se utilizó abordaje submamario e injerto de piel total del complejo areola pezon (CAP); otras tecnicas fueron periareolar, incisión en T y  liposucción. La complicación mas frecuente fue la colección. Biopsia normal en un 100 % .  Discusión: Experiencia pionera en Chile, realizada en un Hospital Público, en el difícil proceso de reasignación de género, en la problación transexual de Chile. Individuos muy estigmatizados de parte de la comunidad, que encontraron  en el Servicio de Salud de Talcahuano, una mano amiga, que les extendió su apoyo desinteresado y calificado, logrando excelentes resultados finales.

Author(s):  
Theddeus Octavianus Hari Prasetyono ◽  
Angelica Gracia Budhipramono ◽  
Illona Andromeda

2011 ◽  
Vol 29 (25) ◽  
pp. 3366-3373 ◽  
Author(s):  
Edith A. Perez ◽  
Edward H. Romond ◽  
Vera J. Suman ◽  
Jong-Hyeon Jeong ◽  
Nancy E. Davidson ◽  
...  

Purpose Trastuzumab is a humanized monoclonal antibody against the human epidermal growth factor receptor 2 (HER2). The clinical benefits of adjuvant trastuzumab have been demonstrated in interim analyses of four large trials. Initial data of the combined analysis of the North Central Cancer Treatment Group (NCCTG) N9831 Intergroup trial and National Surgical Adjuvant Breast and Bowel Project (NSABP) B-31 trial were reported in 2005. Long-term follow-up results on disease-free survival (DFS) and overall survival (OS) have been awaited. Patients and Methods Patients with HER2-positive operable breast cancer were randomly assigned to doxorubicin plus cyclophosphamide followed by paclitaxel with or without trastuzumab in the NCCTG N9831 and NSABP B-31 trials. The similar design of both trials allowed data from the control and trastuzumab-containing arms to be combined in a joint analysis. Results At 3.9 years of median follow-up, there continues to be a highly statistically significant reduction in DFS event rate in favor of the trastuzumab-containing arm (P < .001). Similarly, there continues to be a statistically significant 39% reduction in death rate in favor of the trastuzumab-containing arm (P < .001). Conclusion These data demonstrate consistent DFS and OS advantages of adjuvant trastuzumab over time, with the longest follow-up reported to date. The clinical benefits continue to outweigh the risks of adverse effects.


1950 ◽  
Vol 37 (5) ◽  
pp. 112-113 ◽  
Author(s):  
Hermann Pfisterer ◽  
Konrad Schubert
Keyword(s):  

Author(s):  
Riccardo Faucci

- The paper shows the intimate connection among the various branches of Pareto's research interests, in order to reconstruct the genuine path of development of his analysis of human action. A special attention is devoted to the 2006 critical edition of his Manuel.JEL classification: B 13; B 31; B 41.Keywords: Neoclassical thought through 1925; Pareto; Economic Methodology.


1974 ◽  
Vol 2 (4) ◽  
pp. 231-238
Author(s):  
John Q. Owsley ◽  
Dale King

1995 ◽  
Vol 46 (Supplement) ◽  
pp. 65
Author(s):  
T. Takahashi ◽  
N. Watanabe ◽  
H. Tsuji ◽  
M. Hatsukade
Keyword(s):  

1970 ◽  
Vol 1 (4) ◽  
Author(s):  
Tessa Puspita Sari ◽  
Gentur Sudjatmiko

Background: Gynecomastia is a common problem of the male breast, with a reported overall incidence of 32 to 36 percent. The surgical management of gynecomastia has undergone significant changes over the past few decades, from a predominantly open approach to one involving liposuction only or liposuction combined with direct excision through a periareolar or remote incision. Patients and Method: We present five cases with bilateral gynecomastia. One patient is a teenager and others are adult males. Liposuction only was performed in patients without palpable glandular breast mass. Direct excision was made to help remove the excessive glandular breast mass. The compressive garment is worn for 4 to 6 weeks after procedure to prevent the complications of the surgical procedure.Result: Three of the patients are corrected with liposuction only. There are two patients who underwent combination of open excision and liposuction. The liposuction procedure only left minimal scar from canulas incision. Other patient has minimal periareolar incision to remove excess breast tissue. None of the patients showed complication after surgery.Summary: All of the patients presented were satisfied by the correction of gynecomastia using liposuction. None of the patients shows any complication after liposuction procedure. The result after surgery is a natural-looking chest without extensive scar. The patients appreciate the early return to work and normal physical activities.


Sign in / Sign up

Export Citation Format

Share Document